Another study [38] that looked at visceral and subcutaneous fat accumulation in OSA patients treated with CPAP found a significant reduction in these parameters after six months of treatment and a significant decrease in serum leptin levels after three–four days of CPAP therapy. The gene discussed is LEP; the disease is obstructive sleep apnea syndrome.